ORGO - Organogenesis tumbles after pulling 2023 guidance
2023-08-10 13:34:30 ET
More on Organogenesis
- Organogenesis Holdings, Inc. ( ORGO ) Q2 2023 Earnings Call Transcript
- Organogenesis: Solid Revenue Generation From A Hyper-Trading Wound Care Company
- Morgan Stanley starts Organogenesis at equal weight, cites reimbursement issues
- Organogenesis surges ~30% as Wound Care drives Q1 revenue; raises FY23 outlook
- Seeking Alpha’s Quant Rating on Organogenesis Holdings
For further details see:
Organogenesis tumbles after pulling 2023 guidance